Key Market Indicators
Sales of analgesic medicine in Australia are expected to hit $427.4 million by 2026. This is a 1.1% average annual growth from the current level of $405.5 million in 2021. Since 1995, the Australian market has seen an average annual growth of 1.9%. In 2021, the country ranked sixth, behind South Korea, Spain, Canada and Italy.
